Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
A multicentre phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
1. A multicentre phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer A. Choudhury*, R. Swindell*, J. P. Logue*, P. A. Elliott*, J.E. Livsey*, P. Symonds # , J. P. Wylie*, N.W. Clarke*, A. E. Kiltie $ , R.A. Cowan* *The Christie, Wimslow Road, Manchester M20 4BX, # Leicester Royal Infirmary, Leicester LE1 5WW, $ The Gray Institute, Oxford OX3 7DQ J Clin Oncol. 2011 Feb 20;29(6):733-8. Epub 2011 Jan 4.
2.
3.
4. Comparison of RT and surgery: Disease-specific survival Kotwal et al: Int. J. Radiation Oncology Biol. Phys., Vol. 70, No. 2, pp. 456–463, 2008
5.
6.
7.
8. Christie series Cowan. R, McBain. C. et al. Int. J. Radiation Oncology Biol. Phys., Vol. 59, pp. 197-207, 2004 5yr Survival OS: 58% DSS: 65%
9.
10. Results of Canadian Trial Pelvic-recurrence free survival Overall survival Coppin et al: Journal of Clinical Oncology, Vol 14, No 11 (November), 1996: pp 2901-2907
11. Summary of bladder preservation studies to 2010 Rene et al. Curr Oncol > v.16(4); Aug 2009
26. Cause-specific survival of patients with primary v secondary cystectomy Addla et al. The Journal of Urology Vol. 181, Issue 4, Supplement, Page 633